Cytomegalovirus (CMV) Infection: Manifestations by Population

CMV is a ubiquitous herpesvirus. Most infections are asymptomatic, but clinical syndromes vary dramatically by host immunity and timing of acquisition.

1. Congenital CMV (In Utero Infection)

Most common infectious cause of birth defects in developed countries.

  • Symptomatic at birth (10–15%): Petechiae, hepatosplenomegaly, jaundice, microcephaly, chorioretinitis, sensorineural hearing loss, neurodevelopmental delay.
  • Asymptomatic at birth (85–90%): 10–15% later develop hearing loss or subtle neurodevelopmental issues.

2. CMV Mononucleosis (Immunocompetent Adults)

Heterophile-negative mono. Fever, fatigue, lymphadenopathy, pharyngitis, mild hepatitis. Self-limited (2–6 weeks). No specific antiviral needed.

3. CMV in Immunocompromised Hosts

Reactivation or primary infection causes severe, organ-specific disease:

  • CMV Retinitis: Vision loss, floaters; sight-threatening. HIV/AIDS (CD4+ <50), transplant recipients.
  • CMV Colitis/Esophagitis/Gastritis: Abdominal pain, diarrhea, bleeding, odynophagia.
  • CMV Pneumonitis: Hypoxic respiratory failure; high mortality in transplant (especially allogeneic HSCT).
  • CMV Hepatitis/Myocarditis/Encephalitis/Polyradiculopathy: Less common but serious.

4. Diagnosis

  • PCR viral load (quantitative) – blood, CSF, aqueous humor, tissue.
  • Antigenemia (pp65) – older, less sensitive.
  • Histopathology (owl's eye inclusions) – tissue confirmation.

5. Treatment / Prevention

  • Ganciclovir / valganciclovir – first-line.
  • Foscarnet / cidofovir – resistant strains.
  • Letermovir – prophylaxis in HSCT recipients.
  • CMV-safe blood products (leukoreduced/seronegative) for at-risk patients.

Early detection via monitoring (e.g., weekly CMV PCR post-transplant) enables preemptive therapy, preventing end-organ disease.

Viral Infections - Related Articles